GlassScriptPhysician profile
Melissa L Monack
NPI 1265720296
$3,173.93
in general payments reported to CMS, 2019-2025
21 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,230 · 2022: $574 · 2023: $461 · 2024: $594 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $931.92 | 2021-2023 | Twirla |
| Mayne Pharma Commercial LLC | $578.83 | 2021-2025 | |
| Exeltis, USA INC. | $274.04 | 2021-2025 | Slynd |
| Organon LLC | $224.81 | 2021-2025 | Nexplanon |
| Si-Bone, INC. | $155.79 | 2022 | |
| Astellas Pharma US INC | $139.63 | 2021-2025 | Veozah |
| Pfizer INC. | $129.26 | 2021-2024 | |
| Abbvie INC. | $125.95 | 2021-2023 | |
| Mylan Pharmaceuticals INC. | $107.07 | 2021-2022 | |
| Amgen INC. | $100.69 | 2021-2024 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $99.28 | 2021-2024 | Gardasil 9, Gardasil |
| Therapeuticsmd, INC. | $87.20 | 2021 | |
| Evofem Biosciences, INC. | $39.36 | 2021 | |
| Urovant Sciences INC | $36.83 | 2021-2022 | |
| Becton, Dickinson and Company | $35.75 | 2025 | Channel Drain |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.59 | 2024 | |
| Millicent US INC | $22.49 | 2025 | Intrarosa, Femlyv |
| Cumberland Pharmaceuticals, INC. | $17.04 | 2025 | Caldolor |
| Smith+Nephew, INC. | $16.65 | 2023 | Stravix Pl |
| Coopersurgical, INC. | $15.02 | 2024 | Paragard T 380a |
| Avion Pharmaceuticals | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Monack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.